Diagnostic agents for pancreatic exocrine function

Details Diagnostic agents for pancreatic exocrine function Diagnostic agents for pancreatic exocrine function

2006-12-20

2009-08-04

Jones, D. L (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110, C424S001650, C424S001730

Reexamination Certificate

active

07569208

ABSTRACT:
The present invention provides a13C-labeled oligosaccharide or polysaccharide or a salt thereof excluding U—13C-maltose,13C-starch, 1-13C-maltotetraose and 1-13C-amylose; a derivative of the13C-labeled oligosaccharide or polysaccharide or salt thereof; a13C-labeled inclusion complex or a salt thereof, which comprises a cyclodextrin or a modified derivative thereof as a host molecule; a13C- or14C-labeled fluorescein ester compound or a salt thereof; and a diagnostic agents for pancreatic exocrine function comprising these compounds13C- or14C-labeled.

REFERENCES:
patent: 3786140 (1974-01-01), Meyer-Bertenrath et al.
patent: 3917812 (1975-11-01), Woog et al.
patent: 4676974 (1987-06-01), Hofmann et al.
patent: 5300280 (1994-04-01), DeRosch et al.
patent: 5393660 (1995-02-01), Kitahata et al.
patent: 5405975 (1995-04-01), Kuhn et al.
patent: 5640014 (1997-06-01), Sauke et al.
patent: 6254851 (2001-07-01), Kohno et al.
patent: 6905668 (2005-06-01), Kohno et al.
patent: 7125683 (2006-10-01), Asuka et al.
patent: 4426204 (1995-01-01), None
patent: 1981 2332AI (1999-09-01), None
patent: 0220951 (1987-05-01), None
patent: 2 251 381 (1992-07-01), None
patent: 6-315399 (1994-11-01), None
EP Search Report for EP991307554 dated Jan. 26, 2000.
New Zealand Examination report for NZ No. 337946 dated Sep. 28, 1999.
Decisions on Esau's Application 49 RPC 85, Montecantini Edison's Application [1972] RPC 639 and Electrical Musical Industries Application 56 RPC 39, 41.
Acheson et al., The American Journal of Clinical Nutrition, 41: 881-890 (1985).
Dewit et al., Pediatric research, 32 (1) 45-49 (1992).
Goromaru et al., Biol Pharm. Bull., 17(1): 156-159 (1994).
Harding et al., Isotonpenpraxis Environ. Health Stud., 30: 108 (1994).
Heile et al., Biomedical and environmental Mass Spectrometry, 16: 133-135 (1998).
Hiele et al, J. Lab Clin. Med., 112(2): 193-200 (1988).
Hiele et al., Gastroenterology, 96:503-509(1989).
Hiele et al., Gut., 31:175-178 (1990).
Kohmoto et al., Biosci, Biotech, Biochem, 56(6): 937-940 (1992).
Jindrich et al.:Carbohydrate Research 266 (1995) 75-80.
Lewis, Sr., Hawley's Condensed Chemical Dictionary, 12th Edition, p. 217, 1993.
Löser et al., Z. Gastroenterol, 35:187-194 (1977).
Normand et al., American Journal of Clinical Nutrition, 55: 430-435 (1992).
Rating. et al, European Journal of Pediatrics, XX, Springer Verlag, vol. 156, pp. 18-23, (1997).
Shulman et al, Pediatric Research, 20(8) 740-743 (1986).
Tao et al., Biochimica et Biophysica Act, 995: 214-220 (1989).
Weaver et al., British Journal of Nutrition, 74: 531-537 (1995).
Yu et al., Biochimica et Biophysica Acta, 1244:1-9 (1995).
Office Action for Japanese Patent Application No. H11-263300, mailed Mar. 19, 2007.

Affiliated with

Also associated with

Rating

Diagnostic agents for pancreatic exocrine function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic agents for pancreatic exocrine function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic agents for pancreatic exocrine function will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4121034